Ignet

Gene Information

Gene symbol: SMARCC1

Gene name: SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1

HGNC ID: 11104

Synonyms: BAF155, SRG3, Rsc8, CRACC1

Related Genes

#	Gene Symbol	Number of hits
1	NOTCH1	1 hits
2	THM	1 hits

Related Sentences

#	PMID	Sentence
1	11504912	Notch1 confers a resistance to glucocorticoid-induced apoptosis on developing thymocytes by down-regulating SRG3 expression.
2	11504912	We previously have reported that SRG3 is required for glucocorticoid (GC)-induced apoptosis in the S49.1 thymoma cell line.
3	11504912	The expression of SRG3 also was down-regulated by the activated form of Notch1 (NotchIC).
4	11504912	Expression of transgenic SRG3 resulted in the restoration of GC sensitivity in thymocytes expressing transgenic Notch1.
5	11504912	These results suggest that SRG3 is the downstream target of Notch1 in regulating GC sensitivity of thymocytes.
6	11504912	Notch1 confers a resistance to glucocorticoid-induced apoptosis on developing thymocytes by down-regulating SRG3 expression.
7	11504912	We previously have reported that SRG3 is required for glucocorticoid (GC)-induced apoptosis in the S49.1 thymoma cell line.
8	11504912	The expression of SRG3 also was down-regulated by the activated form of Notch1 (NotchIC).
9	11504912	Expression of transgenic SRG3 resulted in the restoration of GC sensitivity in thymocytes expressing transgenic Notch1.
10	11504912	These results suggest that SRG3 is the downstream target of Notch1 in regulating GC sensitivity of thymocytes.
11	11504912	Notch1 confers a resistance to glucocorticoid-induced apoptosis on developing thymocytes by down-regulating SRG3 expression.
12	11504912	We previously have reported that SRG3 is required for glucocorticoid (GC)-induced apoptosis in the S49.1 thymoma cell line.
13	11504912	The expression of SRG3 also was down-regulated by the activated form of Notch1 (NotchIC).
14	11504912	Expression of transgenic SRG3 resulted in the restoration of GC sensitivity in thymocytes expressing transgenic Notch1.
15	11504912	These results suggest that SRG3 is the downstream target of Notch1 in regulating GC sensitivity of thymocytes.
16	11504912	Notch1 confers a resistance to glucocorticoid-induced apoptosis on developing thymocytes by down-regulating SRG3 expression.
17	11504912	We previously have reported that SRG3 is required for glucocorticoid (GC)-induced apoptosis in the S49.1 thymoma cell line.
18	11504912	The expression of SRG3 also was down-regulated by the activated form of Notch1 (NotchIC).
19	11504912	Expression of transgenic SRG3 resulted in the restoration of GC sensitivity in thymocytes expressing transgenic Notch1.
20	11504912	These results suggest that SRG3 is the downstream target of Notch1 in regulating GC sensitivity of thymocytes.
21	11504912	Notch1 confers a resistance to glucocorticoid-induced apoptosis on developing thymocytes by down-regulating SRG3 expression.
22	11504912	We previously have reported that SRG3 is required for glucocorticoid (GC)-induced apoptosis in the S49.1 thymoma cell line.
23	11504912	The expression of SRG3 also was down-regulated by the activated form of Notch1 (NotchIC).
24	11504912	Expression of transgenic SRG3 resulted in the restoration of GC sensitivity in thymocytes expressing transgenic Notch1.
25	11504912	These results suggest that SRG3 is the downstream target of Notch1 in regulating GC sensitivity of thymocytes.